Joshua Ainomugisha
ID: UNCST-2025-R019411
|
Female Gender Stereotypes, Parental Influence and Female Students’ Engagement in Vocational Training in Nakivale Vocational Training Centre, Isingiro
District, Uganda.
REFNo: SS4759ES
To examine the extent to which female gender stereotypes influence female students' engagement in vocational training in Nakivale Vocational Training Centre.
2. To assess the relationship between parental influence and female students' engagement in vocational training in Nakivale Vocational Training Centre
3. To assess the combined predictive power of female gender stereotypes and parental influence on female students' engagement in vocational training in Nakivale Vocational Training Centre.
4. To find out the mediating effect of parental influence on the relationship between female gender stereotypes and female students' engagement in vocational training in Nakivale Vocational Training Centre.
5. To establish the challenges faced by female students in engaging in vocational training in Nakivale Vocational Training Centre as a result of female gender stereo types and parental influence
|
Uganda |
2026-01-30 19:42:19 |
2029-01-30 |
Social Science and Humanities |
Non-Clinical Trial |
Degree Award |
.jpg)
|
Elias Kumbakumba
ID: UNCST-2022-R011183
|
Childhood Disability: Exploring the burden, community perceptions, caregiver and VHT perspectives, health system and school readiness in Southwestern Uganda
REFNo: HS6976ES
1.To explore community knowledge, beliefs, and stigma related to congenital and acquired childhood disabilities, and to document caregiver experiences, psychosocial burden, and care-seeking behaviors as told by VHTs
2.To catalogue the prevalence, types, and demographic distribution of childhood disabilities in Rubirizi district, South Western Uganda, using both community-level and education system data.
3.To assess the readiness of the health and school systems, and community health workers to support the early identification, referral, and intervention for children with disabilities
4.To develop and share digital stories capturing lived experiences of caregivers of children with disabilities, reflecting key study themes to inform communities, service providers, and policymakers.
|
Uganda |
2026-01-30 19:40:25 |
2029-01-30 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Barbara Acheng
ID: UNCST-2025-R022067
|
INVESTIGATING DATA SHARING ASYMMETRIES AND DEVELOPING A MONITORING FRAMEWORK FOR ANTIMICROBIAL RESISTANCE DATA SHARING IN UGANDA
REFNo: HS6959ES
1. To identify the current AMR sharing practices across the One Health sectors in Uganda.
2. To determine the barriers and enablers to effective inter-sectoral AMR data sharing.
3. To develop a monitoring framework for inter-sectoral AMR data sharing.
|
Uganda |
2026-01-30 19:39:07 |
2029-01-30 |
Medical and Health Sciences |
Non-Clinical Trial |
Degree Award |
|
Suzanne Kiwanuka N
ID: UNCST-2020-R014671
|
Strategic Analytics for a Sustainable and Resilient Health Supply Chain in Uganda: An assessment of the financing landscape, fiscal space, interventions, subnational and last mile supply chain system performance
REFNo: HS7026ES
4. To assess the sub-national and last-mile supply chain system in Uganda, with emphasis on stock-outs, wastage, redistribution practices, coping mechanisms, and community health supply chain functionality. ,3. To analyze recent interventions to address key bottlenecks in Uganda’s health supply chain and develop actionable solutions to strengthen supply chain design, functionality and resilience.,2. To conduct a fiscal space analysis to identify feasible and innovative financing mechanisms that can strengthen, sustain, and improve the resilience of Uganda’s health supply chain.,1. To analyze Uganda’s health funding landscape and assess how recent disruptions have affected the supply chain for essential medicines and health supplies (EMHS).,To assess the current funding landscape, effect of funding disruptions, fiscal space, interventions and last mile supply chain system performance to generate strategic evidence that informs systemic reforms and strengthens the performance, sustainability, and resilience of Uganda’s health supply chain.,
|
Uganda |
2026-01-30 19:37:49 |
2029-01-30 |
Medical and Health Sciences |
|
Non-degree Award |
|
AGNES NAGGIRINYA BWANIKA
ID: UNCST-2019-R001126
|
Evaluating the impact on 90-day survival of post-discharge follow-up strategies delivered to adult patients hospitalized with sepsis across a research network in sub-Saharan Africa [Call for Life – Sepsis (C4L-Sepsis)]
REFNo: HS6882ES
To compare baseline demographic and clinical characteristics between participants who were randomized and those who did not meet randomization criteria (screen failures),To evaluate participant quality of life at 28- and 90-days post discharge period within two study arms.,To evaluate the proportion of participants within the two study arms who require re-admission to hospital during the post-discharge period of 90 days,To evaluate proportion of participants within the two study arms who return for scheduled post discharge follow-up visits ,To evaluate the efficacy on 28-day mortality among participants hospitalized with sepsis randomized to receive one of two post discharge follow-up strategies – EDI versus EDI plus IVR tool,To evaluate the efficacy on 90-day post-discharge mortality among adult participants hospitalized with sepsis randomized to receive one of two post discharge follow-up strategies – EDI versus EDI plus IVR tool,III. To train clinical officers about vitamin D and its application in managing the co-morbidity illnesses under study. This involves training and mentoring of clinical officers so as to acquire knowledge about vitamin D especially in relation to its clinical effects and treatment of malaria, diabetes, HTN, UTIs, and post covid-19 syndrome. This will enable build enough human capacity and willingness to carry out more research about vitamin D.,To develop prototypes of the efficacy doses of vitamin D for each co- morbidity group. From objective II, the efficacy doses (values) of vitamin D will be recorded. Vitamin D prototypes containing different formulations for each co-morbidity illness will be developed. These will be in form of; solutions, powder and inhalers,To establish the efficacy of vitamin D to the co-morbidity illnesses. This involves giving different doses of vitamin D to study participants in each co- morbidity group in addition to the illness’ conventional drugs while monitoring for change using the monitors of change tests/investigations to ascertain these therapeutic effects of Vitamin D.,To develop prototypes of the efficacy doses of vitamin D for each co-morbidity group. ,To explore vitamin D’s therapeutic efficacy to the co-morbidity diseases (malaria, HTN, diabetes, UTIs and post covid-19 syndrome) under study,III. To train clinical officers about vitamin D and its application in managing the co-morbidity illnesses under study. ,II. To develop prototypes of the efficacy doses of vitamin D for each co-morbidity group,I. To establish the efficacy of vitamin D to the co-morbidity illnesses,To explore vitamin D’s therapeutic efficacy to the co-morbidity diseases (malaria, HTN, diabetes, UTIs and post covid-19 syndrome) under study. ,III. To train clinical officers about vitamin D and its application in managing the co-morbidity illnesses under study. This involves training and mentoring of clinical officers so as to acquire knowledge about vitamin D especially in relation to its clinical effects and treatment of malaria, diabetes, HTN, UTIs, and post covid-19 syndrome. This will enable build enough human capacity and willingness to carry out more research about vitamin D,II. To develop prototypes of the efficacy doses of vitamin D for each co-morbidity group. From objective II, the efficacy doses (values) of vitamin D will be recorded. Vitamin D prototypes containing different formulations for each co-morbidity illness will be developed. These will be in form of; solutions, powder and inhalers ,I. To establish the efficacy of vitamin D to the co-morbidity illnesses. This involves giving different doses of vitamin D to study participants in each co-morbidity group in addition to the illness’ conventional drugs while monitoring for change using the monitors of change tests/investigations to ascertain these therapeutic effects of Vitamin D.,To explore vitamin D’s therapeutic efficacy to the co-morbidity diseases (malaria, HTN, diabetes, UTIs and post covid-19 syndrome) under study. This will be achieved by clinical application of vitamin D, assessing and monitoring its effect in the treatment of the respective comorbidity illness as well as developing of different formulations of vitamin D that had effect in each co-morbidity group. ,
|
Uganda |
2026-01-30 19:36:32 |
2029-01-30 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|